Plasma is used as a raw material to produce a category of drugs called plasma protein and related products. Large volumes of plasma are manipulated and manufactured into small amounts of finished product. Within this category of drugs, the products in highest demand are immune globulins. These drugs are needed to treat conditions such as immune and bleeding disorders, and trauma and burn injuries.
For exceptional access to plasma protein and related products not carried on the Canadian Blood Services product formulary, a medical review is required.
Clinicians can request access to the Canadian Blood Services medical review process for alternate product therapy, on behalf of patients who are not able to tolerate specific plasma protein and products. Each patient specific request will be reviewed within 30 days, unless indicated as urgent. Submit all requests to email@example.com.
Search the customer letters section of our website using the term “plasma protein and products” to find related communications about the PPRP formulary and other updates.